Recon: Lilly hits $1 trillion valuation; Notified bodies have capacity…for now
ReconJason Scott
Biologics/ biosimilars/ vaccinesCombination products/companion diagnosticsGenericsGlobalMedical DevicesPharmaceuticalsReconJason ScottBiologics/ biosimilars/ vaccinesCombination products/companion diagnosticsGenericsGlobalMedical DevicesPharmaceuticals